DelveInsight’s ‘Ankylosing Spondylitis – Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the Ankylosing Spondylitis market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Ankylosing Spondylitis Overview
Ankylosing Spondylitis also called as Bechterew’s disease is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. Clinical features of this group include inflammatory back pain, asymmetrical peripheral oligoarthritis (predominantly of the lower limbs), enthesitis, and specific organ involvement such as anterior uveitis, psoriasis, and chronic inflammatory bowel disease. Aortic root involvement and conduction abnormalities are rare complications of AS. AS affects men more often than women.
Some of the key facts of Ankylosing Spondylitis Market Report:
The general onset of Ankylosing Spondylitis commonly occurs in younger people, between the ages of 17 and 45. However, it can also affect children and those who are much older.
Ankylosing Spondylitis Epidemiological Segmentation
Ankylosing Spondylitis (Bekhterevs Disease) prevalent cases
Ankylosing Spondylitis (Bekhterevs Disease) incident cases
Ankylosing Spondylitis (Bekhterevs Disease) diagnosed cases
Ankylosing Spondylitis (Bekhterevs Disease) treatment cases
Got queries? Click here to learn more about the Ankylosing Spondylitis Market Landscape
Ankylosing Spondylitis Market Outlook
Ankylosing spondylitis is an inflammatory disease that, over time, can cause some of the small bones in the spine (vertebrae) to fuse. This fusing makes the spine less flexible and can result in a hunched-forward posture. If ribs are affected, it can be difficult to breathe deeply. There is no cure for Ankylosing Spondylitis, but treatments can lessen your symptoms and possibly slow the progression of the disease.
A common treatment regimen for the various forms of spondyloarthritis involves medication, exercise, physical therapy, good posture practices, and other options such as applying heat/cold to help relax muscles and reduce joint pain. In severe cases, posture-correcting surgery may also be an option.
Ankylosing Spondylitis Market Key Companies working on it
UCB
AbbVie
Pfizer
Astella
Amgen
Novartis
Iroko Pharmaceuticals
Syntex Pharmaceuticals
And many others
Ankylosing Spondylitis Market Key Therapies Covered and Analyzed in the Report:
Bimekizumab
CC-99677
Adalimumab
Infliximab
Etanercept
Sarilumab
Secukinumab
GP2017
Learn more about the Ankylosing Spondylitis Key Companies
Table of Contents
Key Insights
Report Introduction
Executive Summary of Ankylosing Spondylitis Epilepsy Market
Ankylosing Spondylitis Epilepsy Disease Background and Overview
Ankylosing Spondylitis Epilepsy Epidemiology and patient population
Ankylosing Spondylitis Epilepsy Market Emerging Therapies
Ankylosing Spondylitis Epilepsy Market Cancer Market Outlook
Market Access and Reimbursement of Therapies
Appendix
Ankylosing Spondylitis Epilepsy Market Report Methodology
DelveInsight Capabilities
Disclaimer
About DelveInsight
Learn more about the detailed offerings of the report: Ankylosing Spondylitis (Bekhterevs Disease) Epilepsy Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services